IKA Keratoconus Symposium 2023: New data presented for epi-on cross-linking

Video

John D. Gelles, OD, and Steven A. Greenstein, MD, share some insights into the new data on corneal cross-linking presented at IKA Keratoconus Symposium.

Video transcript

John D. Gelles, OD, FAAO, FIAOMIC, FCLSA, FSLS:
I'm John Gelles from the Cornea & Laser Eye Institute, the CLEI Center for Keratoconus.

Steven A. Greenstein, MD:
And I'm Steven Greenstein from the Cornea & Laser Eye Institute as well and the CLEI Center for Keratoconus. We're really excited to be at the first annual IKA meeting; we've heard so many amazing presentations.

We spoke about some of the new and exciting data on cross-linking, particularly epi-on cross-linking and some of the adjunctive treatments like topo-guided PRK and corneal inlays with cross-linking treatment.

Gelles:
Yes, this this lecture was really seminal in this because we're trying to accomplish the concept of comprehensive keratoconus management and going from not just stability, but also what you can do to improve corneal topography and to improve vision for individuals so that you're taking into account not just their vision with contact lenses, but also their vision when they're not wearing their contacts.

Greenstein:
We look forward to the next meeting next year in Washington, DC!

Recent Videos
In 2 weeks, the study participant's dry eye symptoms improved from 76 to 43 on a 0-100 rating scale, according to Marc-Matthias Schulze, PhD, Dipl Ing.
Eye care practitioners reported moderate to high satisfaction with lifitegrast's ability to improve signs of dry eye, according to Melissa Barnett, OD, FAAO, FSLS.
Neda Gioia, OD, CNS, FOWNS, details the positive feedback gained so far from other optometrists that have been prescribing the NutriTears supplement to their dry eye patients.
Damaris Raymondi, OD, FAAO, highlighted the importance of building patient-doctor trust to learn about these practices, which can include non-traditional treatments like chamomile or manuka honey eye drops.
Noreen Shaikh, OD, Magdalena Stec, OD, FAAO, and Brenda Bohnsack, MD, PhD, emphasize that collaboration and communication are key to proper diagnosis and treatment.
Cecilia Koetting, OD, FAAO, DipABO, cited data from a recent student that found that presbyopia treatment with 0.4% pilocarpine led to up to 86% of patients achieving 20/40 or better.
Kerry Giedd, OD, MS, FAAO, was 1 of 20 investigators around the country for a study evaluating the daily disposable contact lens.
According to A. Paul Chous, MA, OD, FAAO, optometrists have an important opportunity to educate patients in their chairs about diabetes.
David Geffen, OD, FAAO, gave a poster presentation titled "Revolutionizing Comfort: Unveiling the Potential of Perfluorohexyloctane Eyedrops for Contact Lens Wearers" at this year's Academy meeting.
Jessica Steen, OD, FAAO, Dipl-ABO, discussed ophthalmic considerations for patients undergoing treatment with antibody drug conjugates for gynecologic cancers at this year's conference.
© 2024 MJH Life Sciences

All rights reserved.